Profound Medical PROF Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Capital Equipment | $8.41M+158% | $6.37M+161% | $4.18M+298% | $3.14M+224% | $3.26M+1,006% | |
| Recurring Non Capital | $10.4M+20.9% | $9.73M+18.1% | $10.12M+39.5% | $8.7M+38.1% | $8.6M+31.5% | |
| Revenue by Geography | ||||||
| CA | $5.8M+82.0% | $3.08M+26.3% | $2.21M+63.5% | $2.41M+121% | $3.19M+1,053% | |
| DE | $697K-25.9% | $773K-13.2% | $686K-42.8% | $820K-39.6% | $940K-39.7% | |
| US | $12.32M+59.3% | $12.25M+66.6% | $11.4M+98.2% | $8.61M+78.6% | $7.74M+54.6% | |
| Total Assets by Geography | ||||||
| CA | $189.28M— | $177.74M— | $173.43M— | —— | —— | |
| CN | $405K— | $412K— | $367K— | —— | —— | |
| DE | $5.24M— | $5.9M— | $6.32M— | —— | —— | |
| FI | $13.1M— | $12.51M— | $12.64M— | —— | —— | |
| US | $34.88M— | $33.75M— | $30.31M— | —— | —— | |
| PP&E (Net) by Geography | ||||||
| CA | $191K— | $243K— | $295K— | —— | —— | |
| US | $1.47M— | $1.2M— | $1.06M— | —— | —— | |
| Depreciation by Geography | ||||||
| CA | $53K-15.2% | $51K-22.7% | $55.5K-12.9% | $56K-8.9% | $62.5K+5.5% | |
| US | $285K-51.2% | $322K-49.8% | $432.25K-33.3% | $515.5K-21.4% | $583.75K-11.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Profound Medical break its business down?
- Profound Medical (PROF) reports revenue by product across 2 parts — Capital Equipment and Recurring Non Capital. Each is extracted from the segment footnotes and tracked over time.
- Where does Profound Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Profound Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
